A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer
NCT01874938
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastric Cancer
Interventions
BIOLOGICAL:
LY2875358
Sponsor
Eli Lilly and Company